[2-(N-phenylanilino)-4-(p-tolyl)thiazol-5-yl]-(2-thienyl)methanone

ID: ALA5282397

Chembl Id: CHEMBL5282397

Max Phase: Preclinical

Molecular Formula: C27H20N2OS2

Molecular Weight: 452.60

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2nc(N(c3ccccc3)c3ccccc3)sc2C(=O)c2cccs2)cc1

Standard InChI:  InChI=1S/C27H20N2OS2/c1-19-14-16-20(17-15-19)24-26(25(30)23-13-8-18-31-23)32-27(28-24)29(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-18H,1H3

Standard InChI Key:  FWGZRKOIYICETM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5282397

    ---

Associated Targets(Human)

PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin COX-1/COX-2 (288 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.60Molecular Weight (Monoisotopic): 452.1017AlogP: 7.88#Rotatable Bonds: 6
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 8.69CX LogD: 8.69
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.25Np Likeness Score: -1.30

References

1. Meshram MA, Bhise UO, Makhal PN, Kaki VR..  (2021)  Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.,  225  [PMID:34479036] [10.1016/j.ejmech.2021.113804]
2. Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K..  (2022)  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.,  13  (5.0): [PMID:35685617] [10.1039/d1md00280e]

Source